[ad_1] Action Points Two parallel phase II trials of next-generation CFTR correctors showed that both VX-445 and VX-659 improved predicted FEV1 when combined with tezacaftor and ivacaftor in cystic fibrosis patients with …
Read More »
[ad_1] Mobile mobile network operator Mint Mobile celebrates its second anniversary with a free trial program now available in the United States, the company announced Tuesday. The move is intended to help …
Read More »
[ad_1] JERUSALEM (Reuters) – Israeli Pharmaceuticals Company PainReform has received approval from the US Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a …
Read More »